Natural history of growth and anaemia in children with epidermolysis bullosa: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
British journal of dermatology. - 182, 6 (2020) , 1437-1448, ISSN: 1365-2133
- Keyword
-
Epidermolysis bullosa
Wachstum
Anämie
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- Creator
- DOI
-
10.1111/bjd.18475
- URN
-
urn:nbn:de:bsz:25-freidok-1661446
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reimer-Taschenbrecker, Antonia
- Hess, Moritz
- Schwieger-Briel, Agnes
- Kiritsi, Dimitra
- Schauer, Franziska
- Schumann, Hauke
- Bruckner-Tuderman, Leena
- Has, Cristina
- Universität
Time of origin
- 2020
Other Objects (12)
Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Treatment of Epidermolysis bullosa acquisita with dupilumab
Recent advances in understanding and managing epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Case report: Diagnostic and therapeutic challenges in severe mechanobullous epidermolysis bullosa acquisita
Molecular and genetic mechanisms in junctional epidermolysis bullosa
Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Treatment of Epidermolysis bullosa acquisita with dupilumab
Recent advances in understanding and managing epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Case report: Diagnostic and therapeutic challenges in severe mechanobullous epidermolysis bullosa acquisita
Molecular and genetic mechanisms in junctional epidermolysis bullosa
Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Treatment of Epidermolysis bullosa acquisita with dupilumab
Recent advances in understanding and managing epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Case report: Diagnostic and therapeutic challenges in severe mechanobullous epidermolysis bullosa acquisita